C07D 225/04
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D225/04 (Condensed with carbocyclic rings or ring systems) appears on 236 US grants and 189 published applications in this corpus.
Search patents in C07D- Granted patents
- 236
- Published applications
- 189
- Assignees
- 131
- Inventors
- 622
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 6 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 7 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 0 |
| 2002 | 15 | 8 |
| 2003 | 5 | 16 |
| 2004 | 14 | 4 |
| 2005 | 8 | 11 |
| 2006 | 4 | 7 |
| 2007 | 6 | 7 |
| 2008 | 6 | 9 |
| 2009 | 6 | 22 |
| 2010 | 11 | 5 |
| 2011 | 3 | 9 |
| 2012 | 4 | 8 |
| 2013 | 9 | 5 |
| 2014 | 5 | 8 |
| 2015 | 8 | 7 |
| 2016 | 4 | 9 |
| 2017 | 6 | 5 |
| 2018 | 5 | 7 |
| 2019 | 6 | 6 |
| 2020 | 2 | 9 |
| 2021 | 6 | 5 |
| 2022 | 5 | 4 |
| 2023 | 1 | 4 |
| 2024 | 6 | 7 |
| 2025 | 5 | 3 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Benzonitric heterocyclic compound, preparation method therefor and use thereof18 Aug 2026US 12,709,600 B2Shanghai Institute of Pharmaceutical Industry
- Macrocycles as factor xia inhibitors2 Sep 2025US 12,404,274 B2Bristol-Myers Squibb Company
- Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors to reduce detrimental effects of perfusion deficiency of parenchymal organs24 Jun 2025US 12,337,001 B2
- Organic electroluminescent compound and organic electroluminescent device comprising the same22 Apr 2025US 12,284,910 B2Rohm and Haas Electronic Materials Korea Ltd.
- Molecular degraders of extracellular proteins25 Feb 2025US 12,234,256 B2Yale University
- Spiromacrocyclic orexin 2 receptor agonists28 May 2026US 2026/0144795 A1H. Lundbeck A.S.
- Reblastatin derivative and its use in nervous system diseases28 May 2026US 2026/0146027 A1Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences
- Molecular degraders of extracellular proteins7 May 2026US 2026/0125410 A1
- Functionalized Conjugation Crosslinkers and Uses Thereof1 Jan 2026US 2026/0001840 A1Azvlz, Inc.
- Molecular degraders of extracellular proteins25 Dec 2025US 2025/0388614 A1
Most cited
By later US patents
- Geldanamycin derivatives and antitumor drug89US 4,261,989 AKaken Chemical Co., Ltd. · 1981
- Methods and compositions for destruction of selected proteins74US 6,670,348 B1Sloan-Kettering Institute for Cancer Research · 2003
- Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne65US 10,266,502 B2Synaffix B.V. · 2019
- Condensed heterocyclic ketone derivatives and their use51US 5,462,934 ATakeda Chemical Industries, Ltd. · 1995
- Tricyclic benzazepine vasopressin antagonists50US 5,512,563 AAmerican Cyanamid Company · 1996